Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galectin Therapeutics Inc (NASDAQ:GALT)

2.65
Delayed Data
As of 3:59pm ET
 -0.13 / -4.68%
Today’s Change
2.50
Today|||52-Week Range
6.60
-23.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization9.0K9.0K12.0K10.0K
 
 
 
 
 
 
Operating ExpensesGross Income-9.0K-9.0K-12.0K-10.0K
 
 
 
 
 
General Expenses10.4M9.9M12.1M15.3M
 
 
 
 
 
Research And Development3.6M4.5M5.7M8.4M
 
 
 
 
 
Total Operating Expenses10.4M9.9M12.1M15.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.4M-9.9M-12.1M-15.3M
 
 
 
 
 
Extraordinary Credit0.00200.0K0.000.00
 
 
Extraordinary Charge-524.0K0.000.00-150.0K
 
 
 
Pre-Tax Equity Earnings0.000.00---400.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.9M-9.7M-12.1M-15.8M
 
 
 
 
 
Preferred Dividend-1.8M-976.0K-867.0K-943.0K
 
 
 
 
 
Net Income-10.9M-9.9M-21.1M-16.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.0M15.1M16.9M21.8M
 
 
 
 
 
Shares To Calculate EPS Diluted12.0M15.1M16.9M21.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$6.36-$0.72-$1.30-$0.78
 
 
 
 
 
EPS Diluted-$1.08-$0.72-$1.30-$0.78